Alcohol consumption on liver function and its prognostic value in male patients with hepatocellular carcinoma: a retrospective cohort study

被引:0
|
作者
Zhou, Lei [1 ]
Pang, Qing [1 ,2 ]
Liu, Hui-Chun [1 ]
Jin, Hao [1 ]
Qu, Kai [2 ]
Xu, Xin-Sen [2 ]
Wang, Yong [1 ]
机构
[1] Bengbu Med Coll, Affiliated Hosp 1, Dept Hepatobiliary Surg, Bengbu 233004, Anhui, Peoples R China
[2] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China
关键词
Alcohol; hepatocellular carcinoma; survival; aspartate aminotransferase; gamma-glutamyltranspeptidase; ALPHA-FETOPROTEIN; HEPATITIS-C; NON-B; RISK; CANCER; HEPATOCARCINOGENESIS; RECURRENCE; MORTALITY; THERAPY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and Objective: Alcohol consumption has been proposed to be a main risk factor for hepatocellular carcinoma (HCC), especially in males. We aimed to investigate the effects of alcohol consumption on liver function in patients with HCC. We also explored the prognostic value of alcohol use in HCC. Methods: The medical records on 479 male HCC patients who underwent radical therapy between 2002 and 2012 were retrospectively reviewed. Kaplan-Meier curve, log-rank test, and Cox regression analysis were used to compare the overall survival (OS) and disease-free survival (DFS) between drinkers and non-drinkers. Results: A total of 138patients had a habit of alcohol use. Compared with non-drinkers, drinkerstended to have a high prevalence of cirrhosis (P = 0.004), an elevated levels of alanine aminotransferase (ALT) (P = 0.007) and gamma-glutamyltranspeptidase (GGT) (P < 0.001). A potential dose response relationship was also indicated between alcohol consumption and levels of liver enzymes. When stratified according to etiology, log-rank test identified drinking as a significant factor for predicting poor OS as well as DFS in non-hepatitis B non-hepatitis C (NBNC) related HCC (both P < 0.05) but not in hepatitis B or C virus induced HCC (both P > 0.05). In addition, alcohol consumption was more likely to affect survival in the subgroups of patients with younger age, presence of cirrhosis, higher level of AFP, larger tumor diameter, and single neoplasm. Multivariate analysis showed that drinking, tumor size, and TNM stage were the three independent predictors for OS and DFS in NBNC-related HCC patients. Conclusions: Alcohol consumption significantly elevated the levels of liver enzymes, increased the risk of cirrhosis, and reduced the survival time in male HCC patients, especially in those without infection of hepatitis virus.
引用
收藏
页码:11835 / +
页数:12
相关论文
共 50 条
  • [1] Total tumor volume as a prognostic value for survival following liver resection in patients with hepatocellular carcinoma. Retrospective cohort study
    Zakaria, Hazem M.
    Macshut, Mahmoud
    Gaballa, Nahla K.
    Sherif, Ahmed E.
    Abdel-Samea, Mohammed E.
    Abdel-Samiee, Mohamed
    Marwan, Ibrahim
    Yassein, Taha
    [J]. ANNALS OF MEDICINE AND SURGERY, 2020, 54 : 47 - 53
  • [2] Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study
    Lu, Zhenhua
    Sun, Zhen
    Liu, Chengyu
    Shi, Xiaolei
    Li, Rui
    Shao, Weiwei
    Zheng, Yangyang
    Li, Yao
    Song, Jinghai
    [J]. BMC CANCER, 2021, 21 (01)
  • [3] Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study
    Zhenhua Lu
    Zhen Sun
    Chengyu Liu
    Xiaolei Shi
    Rui Li
    Weiwei Shao
    Yangyang Zheng
    Yao Li
    Jinghai Song
    [J]. BMC Cancer, 21
  • [4] Prognostic Value of Liver Biomarkers in Hepatocellular Carcinoma Patients Undergoing Yttrium 90 Transarterial Radioembolization (TARE): A Retrospective Pilot Study
    Molano, Maria del Pilar Bayona
    Kolber, Marcin
    V. Barrera, Juana
    Akram, Muhammad R.
    Alnablsi, Mhd Wisam
    Pothini, Tanya
    Salem, Riad
    Singal, Amit G.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [5] The retrospective cohort study on radiotherapy in patients with advanced hepatocellular carcinoma
    Eun, H. S.
    Lee, B. S.
    Lee, E. S.
    Moon, H. S.
    Kim, K. S.
    Kim, S. Y.
    Jung, I. S.
    Lee, H. Y.
    Kim, M. J.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 157 - 158
  • [6] Prognostic nomogram for hepatocellular carcinoma with fibrosis of varying degrees: a retrospective cohort study
    Zhang, Rui
    Chen, Jie
    Jiang, Yingyi
    Wang, Jian
    Chen, Shiyao
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [7] Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients:A retrospective cohort study
    Zhie Fang
    Yuming Guo
    Zhilei Wang
    Tingting He
    Jiabo Wang
    Zhaofang Bai
    Xiaohe Xiao
    [J]. Chinese Herbal Medicines, 2022, (03) - 475
  • [8] Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients: A retrospective cohort study
    Fang, Zhi-e
    Guo, Yuming
    Wang, Zhilei
    He, Tingting
    Wang, Jiabo
    Bai, Zhaofang
    Xiao, Xiaohe
    [J]. CHINESE HERBAL MEDICINES, 2022, 14 (03) : 470 - 475
  • [9] Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients:A retrospective cohort study
    Zhi-e Fang
    Yuming Guo
    Zhilei Wang
    Tingting He
    Jiabo Wang
    Zhaofang Bai
    Xiaohe Xiao
    [J]. Chinese Herbal Medicines, 2022, 14 (03) : 470 - 475
  • [10] Dexmedetomidine ameliorates liver injury and maintains liver function in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study with propensity score matching
    Wang, Xiaoqiang
    Li, Yi-ran
    Shi, Yumiao
    Li, Xiaoying
    Luo, Jiamei
    Zhang, Yiqi
    Qi, Bo
    Wu, Feixiang
    Sun, Yuming
    Pan, Zhiying
    Tian, Jie
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13